Original ResearchPublished 9 October 2026Healthcare professionals' perspectives on diagnostic delay in rare cancers and options for patient support: a qualitative interview studyFemke Krause · Liza A. Hoveling · Rosalie Wilbrink · Denise Abbel · Kristel M. van Asselt · Filip de Vos · Saskia F. A. DuijtsFrontiers in Psychologydoi 10.3389/fpsyg.2026.1945741
ReviewPublished 23 September 2026Therapeutic reprogramming of natural killer cells for solid tumors: expanding frontiers into rare and ultra-rare malignanciesFrancesca Rosato · James W. HodgeFrontiers in Molecular Biosciencesdoi 10.3389/fmolb.2026.1955532